
Stifel’s mood swing
Onto Innovation just got a nicer-looking note from Stifel, which upgraded the stock to Buy from Hold and raised its price target to $350 from $220. The reason? Recent product qualifications and customer developments that apparently have Stifel thinking the company’s setup is looking a lot healthier than the market has been pricing in.
Why investors care
This isn’t a flashy merger or a headline-grabbing product launch. It’s one of those Wall Street moments where a big-name analyst basically says, “Hey, the story may be better than the stock price suggests.” And with Onto already trading at a chunky premium — it’s been up 132% over the past year — this upgrade is less about discovery and more about whether the market still has room to keep paying up.
The valuation debate gets spicy
Stifel says the stock trades at about a 35% valuation gap versus direct peers, which it sees as a disconnect. The new target implies roughly 35 times earnings, but even that would still land at a 10% to 15% discount to peers on an apples-to-apples basis, excluding stock comp. Translation: the analyst thinks the stock is expensive, sure — but maybe not as expensive as it looks compared with the rest of the group.
Big picture
For shareholders, the key question is whether Onto’s packaging progress and customer momentum can keep justifying the rerating. If yes, the stock can keep floating. If not, the valuation crowd is going to start sharpening its knives again.
